C. Jaeger et al., PANCREATIC-ISLET XENOGRAFTS AT 2 DIFFERENT TRANSPLANTATION SITES (RENAL SUBCAPSULAR VERSUS INTRAPORTAL) - COMPARISON OF GRAFT-SURVIVAL AND MORPHOLOGY, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103, 1995, pp. 123-128
Our primary objective in this study was to determine the effect of two
different transplantation sites (renal capsule vs. portal vein) on is
let xenograft survival and graft morphology. 59 chemically induced dia
betic C57BL/6J mice were transplanted either intraportally (n = 30) or
under the left renal capsule (n = 29) receiving 300-350 either freshl
y isolated or culture pretreated (37 degrees C or 22 degrees C) Lewis
rat islets without any immunosuppressive therapy. Histology was perfor
med by immunohistochemical staining to examine the morphologic pattern
after rejection or after post-transplant normoglycemia for more than
120 days. Life table analysis revealed a significant (p < 0.001) prolo
ngation of xenograft survival using the renal capsule as transplantati
on site. 75% graft rejection occurred 56 days after transplantation wh
en the renal capsule was used, compared to 19.5 days intraportal. The
intriguing finding was that graft morphology was different depending o
n the transplantation site. After transplantation under the renal caps
ule we observed predominantly a more periinsular infiltration with foc
al aggregates of mononuclear cells at the periphery of the graft. This
pattern was more consistent with a non-destructive type of insulitis.
In contrast, we found direct infiltration of the transplanted islets
following intraportal transplantation reflecting a more destructive ty
pe of insulitis. In summary, we could demonstrate a significant prolon
gation of islet xenograft survival by using the renal capsule as trans
plantation site in contrast to intraportal transplantation. The morpho
logical pattern possibly indicates two different mechanisms of rejecti
on depending on the transplantation site.